VX1 vs iCAC Device

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

VX1

by Volta Medical

iCAC Device

by Bunkerhill Health

AI Verdict

While both tools fall under the umbrella of Cardiology AI, they address distinct clinical needs and workflows. Tool A, VX1, is designed for real-time assistance during cardiac ablation procedures for arrhythmias, analyzing electrophysiology data. Conversely, Tool B, iCAC Device, focuses on detecting and quantifying coronary artery calcium from CT scans to aid in early cardiovascular disease detection, primarily assisting radiologists.

Choose VX1 if…

Choose VX1 if your electrophysiology lab seeks real-time AI assistance during atrial fibrillation and atrial tachycardia ablation procedures. This tool is ideal for cardiologists aiming to enhance precision, standardize outcomes, and reduce inter-operator variability in identifying dispersed electrograms during live interventions.

View VX1 →

Choose iCAC Device if…

Choose iCAC Device if your institution aims to leverage existing routine chest CT scans for opportunistic screening and early detection of cardiovascular disease. This AI algorithm is best suited for radiologists and cardiologists looking to quantify coronary artery calcium burden to aid in risk stratification and population health initiatives.

View iCAC Device →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	VX1	iCAC Device
Pricing	Contact for pricing	Contact for pricing
Deployment	Software integrated with existing electrophysiology (EP) lab mapping and recording systems.	Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform).
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

VX1

Tool A (VX1) is designed for real-time, intra-procedural use, offering a simple and intuitive user interface that integrates seamlessly with existing EP lab systems and catheters. Its focus on real-time assistance during a complex procedure, without lengthening it, highlights a strong emphasis on immediate and practical usability in a high-stakes environment.

Clinical Value

VX1

Both tools are FDA-cleared and demonstrate clinical utility. However, Tool A (VX1) directly impacts the efficacy and standardization of a complex, interventional cardiac ablation procedure, a field known for operator variability and high recurrence rates. Clinical studies show it reduces inter-operator variability and leads to high freedom from atrial fibrillation.

Pricing & Value

Tie

Both companies require direct contact for pricing information, making a direct comparison of cost-effectiveness impossible. While both articulate strong value propositions in terms of improved outcomes, efficiency, and potential cost reductions, specific ROI data or pricing models are not publicly available for either.

Enterprise Readiness

iCAC Device

Tool B (iCAC Device) explicitly details its cloud-based deployment via the Carebricks platform and integration with standard enterprise systems like PACS, DICOM routers, and EHRs. This comprehensive approach to integration and its platform's support for end-to-end care navigation suggest a more broadly defined and robust enterprise readiness.

Innovation

VX1

Both tools are innovative applications of AI in cardiology. However, Tool A (VX1) stands out for being the first FDA-cleared AI-based tool in interventional cardiac electrophysiology, providing real-time, AI-guided decision support during a live, complex surgical procedure. This real-time, intra-procedural guidance represents a more advanced and dynamic application of AI.

Support & Docs

Tie

Both companies provide evidence of documentation; Tool A mentions a 'User Manual' and 'Brochure', while Tool B refers to a 'Workflow Library'. Without more detailed information regarding the scope, accessibility, and additional support services (e.g., technical support, training), it is not possible to definitively distinguish between the two.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	VX1	iCAC Device
Tool Name	VX1	iCAC Device
Company	Volta Medical	Bunkerhill Health
Primary Clinical Focus	Assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures.	Detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection.
Input Data Analyzed	Dispersed electrograms (EGMs) from 3D anatomical and electrical maps of human atria.	Routine, non-contrast, non-gated chest CT scans.
Key Output/Assistance	AI-guided real-time identification of dispersed electrograms; designed to reduce inter-operator variability and standardize outcomes; provides cycle length estimation.	Estimates presence and quantity of coronary artery calcium (CAC); outputs visual representation of estimated CAC segmentation; delivers exact and four-category quantitative estimates of CAC burden in Agatston units.
Specialties	Cardiology	Cardiology, Radiology

Videos

Demos, reviews, and walkthroughs featuring VX1 and iCAC Device.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of VX1 and iCAC Device?

VX1 assists cardiac electrophysiologists in real-time identification of dispersed electrograms during atrial fibrillation and atrial tachycardia ablation procedures. The iCAC Device detects and quantifies coronary artery calcium from routine chest CT scans to aid in early cardiovascular disease detection.

How do the data input requirements and modalities differ between VX1 and iCAC Device?

VX1 analyzes 3D anatomical and electrical maps of human atria, integrating with existing electrophysiology lab systems. In contrast, the iCAC Device analyzes routine, non-contrast, non-gated chest CT scans, utilizing deep-learning algorithms for its analysis.

Does either tool provide real-time analysis during a procedure, or are they for retrospective analysis?

VX1 provides AI-guided real-time identification of dispersed electrograms during AFib and atrial tachycardia ablation procedures. The iCAC Device, however, analyzes existing routine CT scans for opportunistic identification and quantification of coronary artery calcium, which is a retrospective analysis.

What specific quantitative or qualitative information does each tool provide to the physician?

VX1 provides real-time identification of dispersed electrograms and cycle length estimation from electrograms, aiming to reduce inter-operator variability. The iCAC Device outputs visual representations of estimated CAC segmentation and delivers exact and four-category quantitative estimates of CAC burden in Agatston units.

Which medical specialties are the primary users of each tool?

VX1 is primarily used by cardiac electrophysiologists within the Cardiology specialty. The iCAC Device is designed to provide adjunctive information to radiologists and is relevant for both Cardiology and Radiology specialties.